Obesity-related hypertension and chronic kidney disease: from evaluation to management

Management of obesity Pathophysiology of hypertension
DOI: 10.23876/j.krcp.23.072 Publication Date: 2023-07-28T06:17:54Z
ABSTRACT
With the recent obesity pandemic, obesity-related hypertension and its complications (e.g., heart failure, coronary disease, chronic kidney disease [CKD]) are gaining attention in clinical research fields. Obesity-related frequently precedes onset of CKD aggravates progression. In this review, we discuss role visceral fat pathophysiology potential therapeutic strategies for prevention management. Various factors, including sympathetic nervous system, renin-angiotensin-aldosterone inflammatory pathways, intricately involved pathogenesis hypertension. These factors individually jointly contribute to development (usually sodium-sensitive or resistant hypertension) and, ultimately, progression CKD. From a standpoint, decline renal function advanced further makes blood pressure control challenging since only few options available pressure-lowering medications. Proactive lifestyle modification, pharmacological treatment obesity, bariatric surgery can be considered Furthermore, intensive is required prevent halt
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (100)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....